oasis-4 semaglutide 🥼🧪Slide Deck: Efficacy and safety of oral 25 mg in adults with overweight/obesity: the OASIS 4 RCT : r/Semaglutide 🚨 Oral Semaglutide 25 mg

For non-diabetics taking GLP agonists for other reasons most likely reducing body weight the results of this study may not be applicable as the interaction of diabetes-related inflammation, and such may be the reason for such wide-ranging GLP agonist effects. The study authors conclude that their results provide insights into the benefits and risks of GLP-1R and may be useful for informing clinical care and guiding research agendas

Although face-to-face treatment still plays a vital role in most conditions, remote consultations offer more opportunities to those patients who have logistical or financial obstacles

Doctor-prescribed, delivered, supported

Cohns patients often choose Semaglutide for its predictable results and weekly dosing schedule